Join Clinical trials for Cholera

All Categories Medical Conditions » Food/Water Borne » Cholera

Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200

Condition: Cholera
Interventions: Biological: PXVX0200; Biological: Placebo
Sponsors: PaxVax, Inc.; PaxVax, Inc.
Not yet recruiting - verified April 2012
Evaluation of a Boosting Regimen With Oral Cholera Vaccine

Condition: Cholera
Interventions: Biological: Shanchol™, oral cholera vaccine; Biological: Shanchol™, killed, whole cell, bivalent, oral cholera vaccine; Other: no intervention
Sponsors: International Vaccine Institute; Sachin Desai; National Institute of Cholera and Enteric Diseases, India; Indian Council of Medical Research; SHANTHA BIOTECHNICS LTD
Recruiting - verified May 2012
Bridging Study for Killed Oral Cholera Vaccine in Ethiopia

Conditions: Vibrio Cholerae; Cholera
Interventions: Biological: Killed Bivalent (O1 and O139) whole cell oral cholera vaccine; Biological: Placebo
Sponsors: International Vaccine Institute; International Vaccine Institute; Armauer Hansen Research Institute, Ethiopia; Federal Ministry of Health, Ethiopia; Shantha Biotechnics Limited, India
Not yet recruiting - verified January 2012
Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine

Condition: Cholera
Intervention:
Sponsors: International Vaccine Institute; International Vaccine Institute; Department of Health and Family Welfare, Orissa; Regional Medical Research Center, Orissa
Not yet recruiting - verified March 2012
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Conditions: Infection; Hypertension; Anesthesia; Pain; Reflux
Intervention:
Sponsors: Duke University; Duke University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); The EMMES Corporation
Recruiting - verified April 2012
Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine

Conditions: Immunological Stimulation; Attenuated Vaccine
Intervention: Biological: BMB72 (actA/plcB-deleted Listeria monocytogenes expressing influenza A nucleoprotein)
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012
Study of Alternative Vaccination Schedule of Oral Cholera Vaccine

Conditions: Cholera; Diarrhoea; Vibrio Infection
Interventions: Biological: Modified killed oral cholera vaccine at 14 day interval; Biological: Modified killed oral cholera vaccine at 28 day interval
Sponsors: International Vaccine Institute; International Vaccine Institute; National Institute of Cholera and Enteric Diseases, India; Indian Council of Medical Research; Shantha Biotechnics Limited
Recruiting - verified March 2012
A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children

Condition: Vibrio Cholerae
Intervention: Biological: killed bivalent (O1 and O139)whole cell oral cholera vaccine
Sponsors: International Vaccine Institute; International Vaccine Institute; Shantha Biotechnics Limited; Christian Medical College, Vellore, India
Recruiting - verified March 2012
Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants

Conditions: Cholera; Diarrhea; Vibrio Infections
Interventions: Biological: Bivalent killed oral cholera vaccine; Biological: Killed Escherichia coli K12 placebo
Sponsors: International Vaccine Institute; International Vaccine Institute; Indian Council of Medical Research; National Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics Limited; Institute of Child Health
Not yet recruiting - verified March 2012